OBI Pharma Financials
4174 Stock | TWD 56.40 0.10 0.18% |
OBI |
Understanding current and past OBI Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of OBI Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in OBI Pharma's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in OBI Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of OBI Pharma. Check OBI Pharma's Beneish M Score to see the likelihood of OBI Pharma's management manipulating its earnings.
OBI Pharma Stock Summary
OBI Pharma competes with TaiMed Biologics, PharmaEngine, Medigen Biotechnology, and TTY Biopharm. OBI Pharma, Inc., a bio-pharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. The company was founded in 2002 and is based in Taipei, Taiwan. OBI PHARMA operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange.Instrument | Taiwan Stock View All |
Exchange | Taiwan OTC Exchange |
ISIN | TW0004174008 |
Business Address | No 3, Park |
Sector | Healthcare |
Industry | Biotechnology |
Benchmark | Dow Jones Industrial |
Website | www.obipharma.com |
Phone | 886 2 2655 8799 |
Currency | TWD - New Taiwan Dollar |
You should never invest in OBI Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of OBI Stock, because this is throwing your money away. Analyzing the key information contained in OBI Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
OBI Pharma Key Financial Ratios
There are many critical financial ratios that OBI Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that OBI Pharma reports annually and quarterly.OBI Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OBI Pharma's current stock value. Our valuation model uses many indicators to compare OBI Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OBI Pharma competition to find correlations between indicators driving OBI Pharma's intrinsic value. More Info.OBI Pharma is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the OBI Pharma's earnings, one of the primary drivers of an investment's value.OBI Pharma Systematic Risk
OBI Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. OBI Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on OBI Pharma correlated with the market. If Beta is less than 0 OBI Pharma generally moves in the opposite direction as compared to the market. If OBI Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one OBI Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of OBI Pharma is generally in the same direction as the market. If Beta > 1 OBI Pharma moves generally in the same direction as, but more than the movement of the benchmark.
OBI Pharma January 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of OBI Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of OBI Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of OBI Pharma based on widely used predictive technical indicators. In general, we focus on analyzing OBI Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build OBI Pharma's daily price indicators and compare them against related drivers.
Information Ratio | (0.21) | |||
Maximum Drawdown | 7.69 | |||
Value At Risk | (2.33) | |||
Potential Upside | 1.46 |
Additional Tools for OBI Stock Analysis
When running OBI Pharma's price analysis, check to measure OBI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OBI Pharma is operating at the current time. Most of OBI Pharma's value examination focuses on studying past and present price action to predict the probability of OBI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OBI Pharma's price. Additionally, you may evaluate how the addition of OBI Pharma to your portfolios can decrease your overall portfolio volatility.